304 related articles for article (PubMed ID: 33745419)
1. Characteristics of
Yun T; Koo Y; Kim S; Lee W; Kim H; Chang D; Kim S; Yang MP; Kang BT
Vet Q; 2021 Dec; 41(1):163-171. PubMed ID: 33745419
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.
Karunanithi S; Sharma P; Kumar A; Khangembam BC; Bandopadhyaya GP; Kumar R; Gupta DK; Malhotra A; Bal C
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1025-35. PubMed ID: 23525498
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
[TBL] [Abstract][Full Text] [Related]
4. Imaging Melphalan Therapy Response in Preclinical Extramedullary Multiple Myeloma with
Hathi DK; DeLassus EN; Achilefu S; McConathy J; Shokeen M
J Nucl Med; 2018 Oct; 59(10):1551-1557. PubMed ID: 29700126
[TBL] [Abstract][Full Text] [Related]
5. Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.
Schwarzenberg J; Czernin J; Cloughesy TF; Ellingson BM; Pope WB; Grogan T; Elashoff D; Geist C; Silverman DH; Phelps ME; Chen W
Clin Cancer Res; 2014 Jul; 20(13):3550-9. PubMed ID: 24687922
[TBL] [Abstract][Full Text] [Related]
6. Identify glioma recurrence and treatment effects with triple-tracer PET/CT.
Li C; Yi C; Chen Y; Xi S; Guo C; Yang Q; Wang J; Sai K; Zhang J; Ke C; Chen F; Lv Y; Zhang X; Chen Z
BMC Med Imaging; 2021 May; 21(1):92. PubMed ID: 34059015
[TBL] [Abstract][Full Text] [Related]
7. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W
J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
Tripathi M; Sharma R; D'Souza M; Jaimini A; Panwar P; Varshney R; Datta A; Kumar N; Garg G; Singh D; Grover RK; Mishra AK; Mondal A
Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821
[TBL] [Abstract][Full Text] [Related]
9.
Watabe T; Ikeda H; Nagamori S; Wiriyasermkul P; Tanaka Y; Naka S; Kanai Y; Hagiwara K; Aoki M; Shimosegawa E; Kanai Y; Hatazawa J
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):321-331. PubMed ID: 27550420
[TBL] [Abstract][Full Text] [Related]
10. Exploring the mechanism of 18F-fluorodopa uptake in recurrent high-grade gliomas: A comprehensive histomolecular-positron emission tomography analysis.
Cobes N; Tran S; Mathon B; Nichelli L; Bielle F; Touat M; Kas A; Rozenblum L
Eur J Neurol; 2024 Jan; 31(1):e16093. PubMed ID: 37823694
[TBL] [Abstract][Full Text] [Related]
11. PET Imaging of L-Type Amino Acid Transporter (LAT1) and Cystine-Glutamate Antiporter (x
Krys D; Mattingly S; Glubrecht D; Wuest M; Wuest F
Mol Imaging Biol; 2020 Dec; 22(6):1562-1571. PubMed ID: 32789819
[TBL] [Abstract][Full Text] [Related]
12. ¹⁸F-FLT and ¹⁸F-FDOPA PET kinetics in recurrent brain tumors.
Wardak M; Schiepers C; Cloughesy TF; Dahlbom M; Phelps ME; Huang SC
Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1199-209. PubMed ID: 24604590
[TBL] [Abstract][Full Text] [Related]
13.
Patel CB; Fazzari E; Chakhoyan A; Yao J; Raymond C; Nguyen H; Manoukian J; Nguyen N; Pope W; Cloughesy TF; Nghiemphu PL; Czernin J; Lai A; Ellingson BM
J Neurooncol; 2018 Sep; 139(2):399-409. PubMed ID: 29679199
[TBL] [Abstract][Full Text] [Related]
14. Case Report: 18F-Fluoro-L-Phenylalanine Positron Emission Tomography Findings and Immunoreactivity for L-Type Amino Acid Transporter 1 in a Dog With Meningioma.
Lee D; Yun T; Kim S; Koo Y; Chae Y; Kim S; Chang D; Yang MP; Kim H; Kang BT
Front Vet Sci; 2022; 9():899229. PubMed ID: 35909694
[TBL] [Abstract][Full Text] [Related]
15. 18F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging findings of primary intracranial histiocytic sarcoma in a dog.
Kang BT; Park C; Yoo JH; Gu SH; Jang DP; Kim YB; Woo EJ; Kim DY; Cho ZH; Park HM
J Vet Med Sci; 2009 Oct; 71(10):1397-401. PubMed ID: 19887750
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography with [(18)F]FDOPA and [(18)F]FDG in the imaging of small cell lung carcinoma: preliminary results.
Jacob T; Grahek D; Younsi N; Kerrou K; Aide N; Montravers F; Balogova S; Colombet C; De Beco V; Talbot JN
Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1266-9. PubMed ID: 12856157
[TBL] [Abstract][Full Text] [Related]
17. Imatinib mesylate plus hydroxyurea chemotherapy for cerebellar meningioma in a Belgian Malinois dog.
Jung HW; Lee HC; Kim JH; Jang HM; Moon JH; Sur JH; Ha J; Jung DI
J Vet Med Sci; 2014 Nov; 76(11):1545-8. PubMed ID: 25131949
[TBL] [Abstract][Full Text] [Related]
18. The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma.
Villani V; Carapella CM; Chiaravalloti A; Terrenato I; Piludu F; Vidiri A; Schillaci O; Floris R; Marzi S; Fabi A; Pace A
Anticancer Res; 2015 Sep; 35(9):5117-22. PubMed ID: 26254416
[TBL] [Abstract][Full Text] [Related]
19. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
[TBL] [Abstract][Full Text] [Related]
20. Case Report: Long-Term Chemotherapy With Hydroxyurea and Prednisolone in a Cat With a Meningioma: Correlation of FDG Uptake and Tumor Grade Assessed by Histopathology and Expression of Ki-67 and p53.
Yun T; Koo Y; Kim H; Lee W; Kim S; Jung DI; Yang MP; Kang BT
Front Vet Sci; 2021; 8():576839. PubMed ID: 33575281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
